Dr. Hao-Chen Vivien Chang is the Chief Technology Officer, bringing expertise at the intersection of stem-cell engineering, bioinformatics, and microfluidic system integration. She earned her Ph.D. in Tissue Engineering and Regenerative Medicine through a joint program at National Chung Hsing University and the National Health Research Institutes, Taiwan, and later advanced her interdisciplinary biomedical-engineering research at the Georgia Institute of Technology, USA. ​

​

Dr. Chang spearheaded the development of an ISO 13485-certified microfluidic cell-culture product that has since entered the Japanese and U.S. markets, while also developing photonic biosensing technologies. By combining data-driven decision-making with predictive modeling, she now focuses on automated microfluidic platforms coupled with machine-learning algorithms to enhance organoid quality control and production efficiency—continually driving the company’s innovation and growth in regenerative medicine.​